nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.139	0.282	CbGbCtD
Tiagabine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0936	0.19	CbGbCtD
Tiagabine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0893	0.182	CbGbCtD
Tiagabine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0796	0.162	CbGbCtD
Tiagabine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0467	0.0949	CbGbCtD
Tiagabine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0441	0.0897	CbGbCtD
Tiagabine—SLC6A1—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00713	0.0968	CbGpPWpGaD
Tiagabine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00495	0.0673	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00438	0.0595	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00358	0.0487	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00349	0.0475	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00271	0.0369	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.00259	0.0352	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00257	0.0349	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00249	0.0338	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00229	0.0311	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00228	0.0309	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00221	0.0301	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00216	0.0293	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00212	0.0288	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00208	0.0283	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.00188	0.0255	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00182	0.0247	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0017	0.023	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.0016	0.0217	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00157	0.0214	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00147	0.0199	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00139	0.0189	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0147	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000938	0.0128	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000854	0.0116	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000818	0.0111	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000785	0.0107	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000755	0.0103	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000682	0.00927	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000654	0.00889	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00062	0.00843	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000598	0.00812	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000596	0.00809	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00057	0.00775	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000548	0.00745	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000513	0.00698	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000504	0.00685	CbGpPWpGaD
Tiagabine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00101	CcSEcCtD
Tiagabine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.001	CcSEcCtD
Tiagabine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000435	0.001	CcSEcCtD
Tiagabine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.000993	CcSEcCtD
Tiagabine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000431	0.000992	CcSEcCtD
Tiagabine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000431	0.000992	CcSEcCtD
Tiagabine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00099	CcSEcCtD
Tiagabine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00099	CcSEcCtD
Tiagabine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000429	0.000988	CcSEcCtD
Tiagabine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.000987	CcSEcCtD
Tiagabine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.000984	CcSEcCtD
Tiagabine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000426	0.00098	CcSEcCtD
Tiagabine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00098	CcSEcCtD
Tiagabine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000978	CcSEcCtD
Tiagabine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000422	0.000971	CcSEcCtD
Tiagabine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.000971	CcSEcCtD
Tiagabine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00097	CcSEcCtD
Tiagabine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000968	CcSEcCtD
Tiagabine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000419	0.000964	CcSEcCtD
Tiagabine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.000964	CcSEcCtD
Tiagabine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.000956	CcSEcCtD
Tiagabine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.000956	CcSEcCtD
Tiagabine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.000956	CcSEcCtD
Tiagabine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.000956	CcSEcCtD
Tiagabine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.000953	CcSEcCtD
Tiagabine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.000951	CcSEcCtD
Tiagabine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000413	0.000951	CcSEcCtD
Tiagabine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000412	0.000947	CcSEcCtD
Tiagabine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.000947	CcSEcCtD
Tiagabine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.000945	CcSEcCtD
Tiagabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00041	0.000945	CcSEcCtD
Tiagabine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.000943	CcSEcCtD
Tiagabine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00094	CcSEcCtD
Tiagabine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.000935	CcSEcCtD
Tiagabine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000934	CcSEcCtD
Tiagabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000404	0.000931	CcSEcCtD
Tiagabine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000404	0.000929	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00548	CbGpPWpGaD
Tiagabine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00092	CcSEcCtD
Tiagabine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.000917	CcSEcCtD
Tiagabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.000911	CcSEcCtD
Tiagabine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000394	0.000907	CcSEcCtD
Tiagabine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.000907	CcSEcCtD
Tiagabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.000902	CcSEcCtD
Tiagabine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.000902	CcSEcCtD
Tiagabine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000898	CcSEcCtD
Tiagabine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.000895	CcSEcCtD
Tiagabine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.000886	CcSEcCtD
Tiagabine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.000886	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000384	0.000884	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.000884	CcSEcCtD
Tiagabine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000381	0.000878	CcSEcCtD
Tiagabine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.000878	CcSEcCtD
Tiagabine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000874	CcSEcCtD
Tiagabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.000873	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000376	0.000866	CcSEcCtD
Tiagabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.000865	CcSEcCtD
Tiagabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000376	0.000865	CcSEcCtD
Tiagabine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000375	0.000863	CcSEcCtD
Tiagabine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.000863	CcSEcCtD
Tiagabine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00086	CcSEcCtD
Tiagabine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.000857	CcSEcCtD
Tiagabine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000371	0.000855	CcSEcCtD
Tiagabine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.000855	CcSEcCtD
Tiagabine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000371	0.000854	CcSEcCtD
Tiagabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.000851	CcSEcCtD
Tiagabine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000846	CcSEcCtD
Tiagabine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000367	0.000845	CcSEcCtD
Tiagabine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.000843	CcSEcCtD
Tiagabine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.000841	CcSEcCtD
Tiagabine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000364	0.000837	CcSEcCtD
Tiagabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.000837	CcSEcCtD
Tiagabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000364	0.000837	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.000835	CcSEcCtD
Tiagabine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00083	CcSEcCtD
Tiagabine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00083	CcSEcCtD
Tiagabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00083	CcSEcCtD
Tiagabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00083	CcSEcCtD
Tiagabine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.000829	CcSEcCtD
Tiagabine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000827	CcSEcCtD
Tiagabine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.000823	CcSEcCtD
Tiagabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00082	CcSEcCtD
Tiagabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.000817	CcSEcCtD
Tiagabine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.000815	CcSEcCtD
Tiagabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000353	0.000813	CcSEcCtD
Tiagabine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000353	0.000813	CcSEcCtD
Tiagabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000352	0.000811	CcSEcCtD
Tiagabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000808	CcSEcCtD
Tiagabine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000808	CcSEcCtD
Tiagabine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.000807	CcSEcCtD
Tiagabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.000804	CcSEcCtD
Tiagabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.000804	CcSEcCtD
Tiagabine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.000801	CcSEcCtD
Tiagabine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000347	0.0008	CcSEcCtD
Tiagabine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.0008	CcSEcCtD
Tiagabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000347	0.000799	CcSEcCtD
Tiagabine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.000797	CcSEcCtD
Tiagabine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.000795	CcSEcCtD
Tiagabine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000345	0.000794	CcSEcCtD
Tiagabine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.000794	CcSEcCtD
Tiagabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00079	CcSEcCtD
Tiagabine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.000784	CcSEcCtD
Tiagabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.000784	CcSEcCtD
Tiagabine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000338	0.000778	CcSEcCtD
Tiagabine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000777	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000777	CcSEcCtD
Tiagabine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000771	CcSEcCtD
Tiagabine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000771	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000333	0.00453	CbGpPWpGaD
Tiagabine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000767	CcSEcCtD
Tiagabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000767	CcSEcCtD
Tiagabine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000767	CcSEcCtD
Tiagabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000767	CcSEcCtD
Tiagabine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000765	CcSEcCtD
Tiagabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.000765	CcSEcCtD
Tiagabine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00033	0.000759	CcSEcCtD
Tiagabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.000758	CcSEcCtD
Tiagabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.000758	CcSEcCtD
Tiagabine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.000758	CcSEcCtD
Tiagabine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000755	CcSEcCtD
Tiagabine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.000755	CcSEcCtD
Tiagabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.000754	CcSEcCtD
Tiagabine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000752	CcSEcCtD
Tiagabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000752	CcSEcCtD
Tiagabine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00075	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00443	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00075	CcSEcCtD
Tiagabine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.000744	CcSEcCtD
Tiagabine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000742	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000322	0.00437	CbGpPWpGaD
Tiagabine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00074	CcSEcCtD
Tiagabine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000736	CcSEcCtD
Tiagabine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000728	CcSEcCtD
Tiagabine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000725	CcSEcCtD
Tiagabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000725	CcSEcCtD
Tiagabine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000715	CcSEcCtD
Tiagabine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000715	CcSEcCtD
Tiagabine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.000715	CcSEcCtD
Tiagabine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000713	CcSEcCtD
Tiagabine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000712	CcSEcCtD
Tiagabine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000707	CcSEcCtD
Tiagabine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000304	0.000701	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000303	0.00411	CbGpPWpGaD
Tiagabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.000697	CcSEcCtD
Tiagabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.000697	CcSEcCtD
Tiagabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000687	CcSEcCtD
Tiagabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000687	CcSEcCtD
Tiagabine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000686	CcSEcCtD
Tiagabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000296	0.000682	CcSEcCtD
Tiagabine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.000675	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000293	0.00398	CbGpPWpGaD
Tiagabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000673	CcSEcCtD
Tiagabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.000664	CcSEcCtD
Tiagabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000288	0.000664	CcSEcCtD
Tiagabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.000658	CcSEcCtD
Tiagabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000651	CcSEcCtD
Tiagabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.000649	CcSEcCtD
Tiagabine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.000642	CcSEcCtD
Tiagabine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000279	0.000642	CcSEcCtD
Tiagabine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000273	0.000629	CcSEcCtD
Tiagabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.000627	CcSEcCtD
Tiagabine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000619	CcSEcCtD
Tiagabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.000617	CcSEcCtD
Tiagabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000268	0.000617	CcSEcCtD
Tiagabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.000612	CcSEcCtD
Tiagabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000266	0.000612	CcSEcCtD
Tiagabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.000612	CcSEcCtD
Tiagabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000266	0.000612	CcSEcCtD
Tiagabine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000611	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00359	CbGpPWpGaD
Tiagabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.000608	CcSEcCtD
Tiagabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000264	0.000608	CcSEcCtD
Tiagabine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000608	CcSEcCtD
Tiagabine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.000606	CcSEcCtD
Tiagabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000606	CcSEcCtD
Tiagabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000263	0.000605	CcSEcCtD
Tiagabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00026	0.0006	CcSEcCtD
Tiagabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00026	0.000599	CcSEcCtD
Tiagabine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000598	CcSEcCtD
Tiagabine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000597	CcSEcCtD
Tiagabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000259	0.000596	CcSEcCtD
Tiagabine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000591	CcSEcCtD
Tiagabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000587	CcSEcCtD
Tiagabine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000587	CcSEcCtD
Tiagabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.000583	CcSEcCtD
Tiagabine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000581	CcSEcCtD
Tiagabine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000579	CcSEcCtD
Tiagabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.000578	CcSEcCtD
Tiagabine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000578	CcSEcCtD
Tiagabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.000577	CcSEcCtD
Tiagabine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000577	CcSEcCtD
Tiagabine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000577	CcSEcCtD
Tiagabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.000574	CcSEcCtD
Tiagabine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.000566	CcSEcCtD
Tiagabine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000245	0.000565	CcSEcCtD
Tiagabine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000556	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000237	0.00322	CbGpPWpGaD
Tiagabine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000544	CcSEcCtD
Tiagabine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000542	CcSEcCtD
Tiagabine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00054	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000234	0.00318	CbGpPWpGaD
Tiagabine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000538	CcSEcCtD
Tiagabine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000535	CcSEcCtD
Tiagabine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000526	CcSEcCtD
Tiagabine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000517	CcSEcCtD
Tiagabine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000513	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000508	CcSEcCtD
Tiagabine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000476	CcSEcCtD
Tiagabine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000475	CcSEcCtD
Tiagabine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000472	CcSEcCtD
Tiagabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00045	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00261	CbGpPWpGaD
Tiagabine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000434	CcSEcCtD
Tiagabine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000433	CcSEcCtD
Tiagabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000433	CcSEcCtD
Tiagabine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00043	CcSEcCtD
Tiagabine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000422	CcSEcCtD
Tiagabine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000421	CcSEcCtD
Tiagabine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00042	CcSEcCtD
Tiagabine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000418	CcSEcCtD
Tiagabine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000411	CcSEcCtD
Tiagabine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000404	CcSEcCtD
Tiagabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000399	CcSEcCtD
Tiagabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000399	CcSEcCtD
Tiagabine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000397	CcSEcCtD
Tiagabine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000394	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000169	0.0023	CbGpPWpGaD
Tiagabine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000387	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000167	0.00227	CbGpPWpGaD
Tiagabine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000382	CcSEcCtD
Tiagabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00038	CcSEcCtD
Tiagabine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000376	CcSEcCtD
Tiagabine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000373	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000369	CcSEcCtD
Tiagabine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000364	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000348	CcSEcCtD
Tiagabine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000348	CcSEcCtD
Tiagabine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000346	CcSEcCtD
Tiagabine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000343	CcSEcCtD
Tiagabine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000336	CcSEcCtD
Tiagabine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000332	CcSEcCtD
Tiagabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000331	CcSEcCtD
Tiagabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000331	CcSEcCtD
Tiagabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000329	CcSEcCtD
Tiagabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000329	CcSEcCtD
Tiagabine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000327	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00191	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00188	CbGpPWpGaD
Tiagabine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000315	CcSEcCtD
Tiagabine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000312	CcSEcCtD
Tiagabine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000312	CcSEcCtD
Tiagabine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000304	CcSEcCtD
Tiagabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000302	CcSEcCtD
Tiagabine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000302	CcSEcCtD
Tiagabine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000281	CcSEcCtD
Tiagabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000274	CcSEcCtD
Tiagabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00027	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000117	0.00159	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000115	0.00157	CbGpPWpGaD
Tiagabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000261	CcSEcCtD
Tiagabine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000253	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000108	0.00146	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000106	0.00144	CbGpPWpGaD
Tiagabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000243	CcSEcCtD
Tiagabine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000241	CcSEcCtD
Tiagabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000241	CcSEcCtD
Tiagabine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000239	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00139	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00137	CbGpPWpGaD
Tiagabine—Nausea—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000227	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.2e-05	0.00111	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.43e-05	0.000739	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.29e-05	0.000718	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.91e-05	0.000668	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.89e-05	0.000393	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.85e-05	0.000388	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.6e-05	0.000354	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.4e-05	0.000326	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2e-05	0.000272	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.97e-05	0.000268	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.84e-05	0.00025	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000237	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000161	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000154	CbGpPWpGaD
